Podcast Episode Details

Back to Podcast Episodes
An Interview With Allucent's Marcus Delatte, PhD, on Using Cannabinoids to Treat Patients With Rare Seizure Disorders

An Interview With Allucent's Marcus Delatte, PhD, on Using Cannabinoids to Treat Patients With Rare Seizure Disorders


Season 1 Episode 175


Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Marcus Delatte, PhD, on how the versatile cannabis plant offers innovative treatments for children with Dravet syndrome and Lennox-Gestaut syndrome.


Published on 6 months, 2 weeks ago






If you like Podbriefly.com, please consider donating to support the ongoing development.

Donate